TrialBlood2015

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

Fritz Offner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.